Glucose and lipid metabolism disorders in children and adolescents with spinal muscular atrophy types 2 and 3-Reference-Cited by-同舟云学术

Glucose and lipid metabolism disorders in children and adolescents with spinal muscular atrophy types 2 and 3

Published:2021-04 Issue:4 Volume:31 Page:291-299
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Djordjevic Stefan A.,Milic-Rasic Vedrana,Brankovic Vesna,Kosac Ana,Dejanovic-Djordjevic Ivana,Markovic-Denic Ljiljana,Djuricic Goran,Milcanovic Natasa,Kovacevic Smiljka,Petrovic Hristina,Djukic Milan,Zdravkovic Vera

Publisher

Elsevier BV

Subject

Genetics (clinical),Neurology (clinical),Neurology,Pediatrics, Perinatology and Child Health

Reference49 articles.

1. Spinal muscular atrophy: a timely review;Kolb;Arch Neurol,2011

2. Spinal muscular atrophy: diagnosis and management in a new therapeutic era;Arnold;Muscle Nerve,2015

3. Childhood spinal muscular atrophy: controversies and challenges;Mercuri;Lancet Neurol,2012

4. Spinal muscular atrophy: going beyond the motor neuron;Hamilton;Trends Mol Med,2013

5. Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?;Shababi;J Anat,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic syndrome is common in adults with 5q‐spinal muscular atrophy and impacts quality of life and fatigue;Muscle & Nerve;2024-06-14

2. Acetaminophen treatment in children and adults with spinal muscular atrophy: a lower tolerance and higher risk of hepatotoxicity;Neuromuscular Disorders;2024-01

3. A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models;Human Molecular Genetics;2023-11-08

4. A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models;2023-06-14

5. Metabolic assessment in children with neuromuscular disorders shows risk of liver enlargement, steatosis and fibrosis;Acta Paediatrica;2023-01-12